OPHTHALMIC FORMULATIONS OF TYROSINE KINASE INHIBITORS, METHODS OF USE THEREOF, AND PREPARATION METHODS THEREOF

• 收藏
• 分享

专利权人:

Allgenesis Biotherapeutics Inc.

发明人:

Tan NGUYEN,Chin-yu LAI

申请号：

US15964235

公开号：

US20180243294A1

申请日:

2018.04.27

申请国别(地区):

US

年份:

2018

代理人:

摘要：

Ophthalmic formulations containing nintedanib, or a pharmaceutically acceptable salt thereof are provided. The ophthalmic formulations can contain microparticles or nanoparticles of nintedanib. Also provided are methods of using the ophthalmic formulations for treating ocular surface diseases, such as dry eye disease.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/